This analysis demonstrated that, in contrast to the abundant expression of ERα in the primary tumour, 54.8% of samples lost the expression of ERα in the corresponding lymphatic metastasis (Fig. 1a,b) (Supplementary Table 1). This evidence concerns the gene ESR1 and neoplasm.